Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents (Q34047187)

30 July 2017

1 reference

title

Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents (English)

1 reference

30 July 2017

1 reference

1 reference

Agarwal R

1

1 reference

PubMed ID

11007941

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

Biochemical Pharmacology

1 reference

30 July 2017

60

1 reference

30 July 2017

8

1 reference

30 July 2017

1051-1059

1 reference

Do diet and androgens alter prostate cancer risk via a common etiologic pathway?

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Nutrition and prostate cancer: a proposal for dietary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Androgen deprivation as a strategy for prostate cancer chemoprevention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Cancer chemoprevention: principles and prospects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Recent advances in chemoprevention of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

An overview of chemoprevention: current status and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

The causes and prevention of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Tyrosine kinase inhibition: an approach to drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

c-erbB-2 oncogene expression in prostatic intraepithelial neoplasia: mounting evidence for a precursor role

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Principles of CDK regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

G1 phase progression: cycling on cue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Diet-hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Inhibitory effect of silymarin, an anti-hepatotoxic flavonoid, on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and mRNA in SENCAR mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Protective effects of silymarin against photocarcinogenesis in a mouse skin model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Soy intake and cancer risk: a review of the in vitro and in vivo data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Genistein, a component of soy, inhibits the expression of the EGF and ErbB2/Neu receptors in the rat dorsolateral prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Phytoestrogen intake and prostate cancer: a case-control study using a new database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

ErbB kinases and NDF signaling in human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900385-3

10.1016/S0006-2952(00)00385-3

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11007941